In a groundbreaking move, the US Food and Drug Administration (FDA) has approved Dexcom's Stelo Glucose Sensor System as the first non-prescription continuous blood glucose monitor (CGM) for children two years of age and older. Previously approved for adults, the device has now become a key tool for managing the health of non-insulin-dependent children to increase glycemic (blood sugar) awareness among this age group with real-time monitoring.